President Cyril Ramaphosa has acknowledged in court papers that article 19 of the controversial Expropriation Act creates a ...
O AHF Global Public Health Institute para a América Latina e Caribe, em parceria com o Instituto Nacional de Saúde Pública do ...
Source: ‘Miracle’ HIV shot rollout in Zimbabwe sparks debate – DW – 10/16/2025 Zimbabwe is among 10 nations rolling out ...
The AHF Global Public Health Institute for Latin America and the Caribbean, in collaboration with the National Institute of ...
In response, the South African National Treasury allocated R750 million in emergency funding to prevent service interruptions ...
South Africa advances HIV prevention with the lenacapavir rollout in 2026, and the US approves the PEPFAR Bridge Plan for six ...
Zimbabwe is among 10 nations rolling out lenacapavir, a twice-yearly HIV prevention shot. "We are excited to announce that ...
New EACS 2025 data show once-weekly islatravir and lenacapavir maintain HIV viral suppression for 96 weeks with no resistance ...
The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...
ViiV found by GSK (GSK) and Pfizer (PFE) are in focus as its long acting HIV PrEP therapy cabotegravir outperforms Gilead's lenacapavir in Phase 1 trial. Read more here.
More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...